Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IMRN save search
Immuron to host Live Virtual Event
Published: 2024-04-15 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -5.47%
Immuron Travelan® sales continued strong growth
Published: 2024-04-10 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 7.08%
H: 4.75%
C: 1.36%
travelan sales growth
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Published: 2024-03-07 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 104.23%
H: 76.85%
C: 35.01%
travelan positive trials results
Immuron Presentation Australian Biologics Festival 2024
Published: 2024-02-21 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -0.01%
H: 1.67%
C: -2.77%
presentation
Immuron achieves record Travelan® sales
Published: 2024-02-13 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 3.67%
H: 1.06%
C: 1.06%
travelan sales
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -1.67%
H: 0.56%
C: 0.56%
presentation
Immuron achieves record half yearly Travelan® sales
Published: 2024-01-16 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
| Email alert
Add to watchlist
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
travelan sales
Immuron Clinical Trials Update
Published: 2023-12-22 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 2.82%
H: 0.0%
C: -2.74%
update trials
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
Published: 2023-12-04 (Crawled : 11:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.52%
study
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 1.04%
H: 7.18%
C: 4.62%
presentation
Immuron CEO Steven Lydeamore Investor Webinar Presentation
Published: 2023-11-13 (Crawled : 23:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 4.12%
H: 6.78%
C: 6.78%
ceo presentation
Immuron CEO Steven Lydeamore presented at AusBioInvest
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -6.06%
H: 9.32%
C: 9.32%
ceo
Immuron Announces Travelan® Clinical Study Cohort 2 commences
Published: 2023-10-18 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -2.63%
H: 2.43%
C: 2.43%
travelan study
Immuron achieves record quarterly Travelan® sales
Published: 2023-10-11 (Crawled : 10:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 6.48%
H: 4.35%
C: -5.22%
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 2.7%
H: 2.63%
C: -1.05%
travelan sales
Immuron achieves record monthly Travelan® sales
Published: 2023-09-13 (Crawled : 10:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.59%
H: 2.57%
C: -1.29%
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -4.12%
H: 8.54%
C: 8.06%
travelan sales
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright - September 11, 2023
Published: 2023-09-11 (Crawled : 12:00) - biospace.com/
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -4.0%
H: 3.13%
C: 1.56%
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
Published: 2023-09-11 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -4.0%
H: 3.13%
C: 1.56%
Immuron to present at the Military Health System Research Symposium
Published: 2023-08-14 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: 0.52%
H: 3.09%
C: 2.75%
health symposium research system military
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
Published: 2023-07-25 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -3.63%
H: 6.19%
C: 4.12%
travelan study
Immuron CEO, Steven Lydeamore to present at Bioshares
Published: 2023-07-24 (Crawled : 10:00) - globenewswire.com
IMRN | $2.45 1.66% -9.28% 9.6K
|
Health Technology
|
| O: -4.9%
H: 4.64%
C: 3.76%
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.